Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-02-22 @ 3:57 PM
Study NCT ID:
NCT02756650
Status:
COMPLETED
Last Update Posted:
2020-06-11
First Post:
2016-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
Sponsor:
Novartis Pharmaceuticals
Organization: